Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors

Raffaella Bucciardini, Marco Floridia, Silvia Baroncelli et al.|International Journal of STD & AIDS|2012

Cited by 10